3. Introduction

4. Antiplatelet Agents

5. ADP Receptor Antagonists

6. CURE Reduction in Cardiovascular Events With Clopidogrel

7. TRITON-TIMI 38 Risk Reduction Prasugrel vs Clopidogrel

8. PLATO Major Events: Ticagrelor vs Clopidogrel

9. Onset of Action

10. Randomized Trials of Antiplatelet Agents TRITON-TIMI 38 and PLATO

11. TRANSLATE-ACS

12. After the Patient Goes Home…

13. Antiplatelet Use After PCI

14. Hospitalized Bleeding

15. TRANSLATE-ACS Factors Associated With In-hospital Switch From 1st- to 2nd-generation ADP Receptor Inhibitor

16. TRANSLATE-ACS Factors Associated With In-hospital Switch From 2nd to 1st -generation ADP Receptor Inhibitor

17. Genetic Effects on Pharmacokinetic and Pharmacodynamic Responses to Clopidogrel

18. TRITON-TIMI 38 Risk Reduction: Prasugrel vs Clopidogrel

19. TRANSLATE-POPS Design

20. POPS – Change in Treatment

21. Summary

22. Abbreviations

23. Abbreviations (cont)

24. References

25. References (cont)

26. References (cont)

27. References (cont)